|1.||Lee, Min Won: 5 articles (04/2012 - 12/2002)|
|2.||Shoyama, Yukihiro: 3 articles (01/2015 - 01/2014)|
|3.||Tung, Nguyen Huu: 3 articles (01/2015 - 01/2014)|
|4.||Choi, Young Wook: 3 articles (12/2013 - 01/2010)|
|5.||Choi, Sun Eun: 3 articles (08/2010 - 10/2008)|
|6.||Edoh, Dominic: 2 articles (01/2015 - 01/2014)|
|7.||Morinaga, Osamu: 2 articles (01/2015 - 01/2014)|
|8.||Uto, Takuhiro: 2 articles (01/2015 - 01/2014)|
|9.||Lee, Chung Soo: 2 articles (04/2012 - 08/2010)|
|10.||Seo, Seong Jun: 2 articles (08/2010 - 01/2010)|
|1.||Melanoma (Melanoma, Malignant)
12/01/2013 - "Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model."
08/01/2002 - "Enhancement of NK cytotoxicity, antimetastasis and elongation effect of survival time in B16-F10 melanoma cells by oregonin."
12/01/2013 - "Treatment doses of oregonin were administered three times weekly, for 30 days from the 11th day after transplantation of the melanoma cells, in each group. "
08/01/2002 - "Moreover, oregonin significantly reduced the incidence of pulmonary metastasis, which may be developed from B16-F10 melanoma cells. "
|2.||Atopic Dermatitis (Atopic Eczema)
01/01/2010 - "Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice."
08/01/2010 - "Effect of topical application and intraperitoneal injection of oregonin on atopic dermatitis in NC/Nga mice."
01/01/2010 - "To develop an external preparation of oregonin (ORG) for the treatment of atopic dermatitis (AD), conventional creams (CC) and elastic liposomes (EL) containing ORG have been formulated and examined for their in vitro skin permeation properties and in vivo therapeutic efficacy assessments. "
12/01/2013 - "Oregonin has been reported to act as a mediator of antibiosis, a liver-protective agent, an antioxidant, an anti-inflammatory agent, and to prevent cancer outbreaks. "
08/01/2010 - "The diarylheptanoid, oregonin (ORE), which was isolated from the bark of Alnus japonica Steudel that grows natively in Korea, has been known to exert antioxidative, anti-inflammatory, anti-cancer and immune response inhibitory effects. "
08/01/2002 - "To evaluate the cytotoxicity of oregonin against tumor cells, we examined the effectiveness of NK cells and determined that oregonin could increase NK cell cytotoxicity. "
08/01/2002 - "MTT assays and NO production tests were performed in order to investigate the cytotoxicity of oregonin in tumor cells and to examine its influence on macrophage in detail. "
01/01/2015 - "We investigated the antiproliferative activity of hirsutanone (Hir) and oregonin (Ore) in human cancer cell lines and elucidated their mechanisms of action. "
|4.||Neoplasm Metastasis (Metastasis)
12/01/2002 - "Four diarylheptanoids, (5R-1,7-bis (3,4-dihydroxyphenyl)-heptane-5-O-beta-D-glucoside (1), (5R) 1,7-bis (3,4-dihydroxyphenyl)-heptane-5-ol (2), oregonin (3), hirsutanonol (4), were isolated from the bark of Alnus hirsuta Turcz and its inhibitory effects on melanogenesis by measuring the melanin level and tyrosinase activity in B16 melanoma cell were examined. "
|7.||NADPH Oxidase (NAD(P)H oxidase)
|8.||Monophenol Monooxygenase (Tyrosinase)
|9.||NADPH Dehydrogenase (Dehydrogenase, NADP)
|1.||Transplantation (Transplant Recipients)